Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xibiao Jia"'
Autor:
Xiao Wei, Mingzhu Song, Chan Huang, Qiao Yu, Guirong Jiang, Guanghao Jin, Xibiao Jia, Zheng Shi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo provide a systematic review of existing meta-analysis on the efficacy, safety and pharmacokinetics of the novel Polo-like kinase-1 (Plk1) inhibitors in various tumor treatments, and assess the methodological quality and the strength of ev
Externí odkaz:
https://doaj.org/article/9ca441e1542e460a89e0e0d60d0408d9
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128886 (2015)
Chemoresistance remains a major obstacle to effective treatment in patients with ovarian cancer, and recently increasing evidences suggest that miRNAs are involved in drug-resistance. In this study, we investigated the role of miRNAs in regulating ci
Externí odkaz:
https://doaj.org/article/920451fda6af44c7bc1e51805d8c080b
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e75849 (2013)
ObjectiveTo analyze the clinic-pathological characteristics of women with cervical cancers in southwestern China and discuss the features and prognosis of young patients.MethodsA retrospective study was performed, which consisted of 1,543 patients di
Externí odkaz:
https://doaj.org/article/0a0c32be509f4f26b6e5626a113cb7e8
Autor:
Sixia Xie, Xibiao Jia, Tingting Li, Yuanyuan Xu, Weiwei Wu, Yichao Qiu, Shuang Yuan, Xue Peng, Hongjing Wang
Publikováno v:
Medicine. 101(31)
There are debates on the management of immature ovarian teratoma and its recurrence. This study aimed to report the incidence of pelvic masses after surgery for immature ovarian teratoma and to identify prognostic factors of disease-free survival aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aeca47a5e0a27d096063ff56090303a
https://pubmed.ncbi.nlm.nih.gov/35945757
https://pubmed.ncbi.nlm.nih.gov/35945757
Autor:
Xiaogang Liu, Yu Zeng, Xibiao Jia, Ming Li, Yan Huang, Zaoming Feng, Maomao Chen, Xueyi Yang, Xian Su
Publikováno v:
Oncology Letters
Epithelial ovarian cancer (EOC) is the most common type of ovarian cancer, which exhibits invasive traits. MicroRNAs (miRNAs/miRs) have been demonstrated to serve important functions in the pathogenesis of EOC. However, the function of miR-545 in EOC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104a762c9ed37a95402d7d0516c61f52
http://europepmc.org/articles/PMC5876444
http://europepmc.org/articles/PMC5876444
Publikováno v:
Cancer Plus. 3:9
Ovarian cancer ranks fifth in cancer death among women. The 5-year relative survival of all stages ovarian cancer is 47%. Identification of new molecular targets is required for the development of targeted therapy. MicroRNA (miRNA) are small, highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb68aed43c1b47e64d2e265e68a6ab5c
https://doi.org/10.18063/cp.v3i1.294
https://doi.org/10.18063/cp.v3i1.294